BTK inhibition in Waldenström’s macroglobulinemia: trial updates and real-world insights
BTK inhibition in Waldenström’s macroglobulinemi
BTK inhibition in Waldenström’s macroglobulinemi
Early-phase trials investigating novel agents in
Marginal zone lymphoma: benefits of BTK inhibiti
Updates and ancillary analyses in the setting of
Preface – EHA 2022 Matthew S. Davids, M
ASCO/EHA/ICML 2021 – Roger Owen Roger Owen summar
ASCO/EHA/ICML 2021 - Christian Buske Christian Bu
Novel bispecific antibodies in CD20-positive B-c
ASCO/EHA/ICML 2021 - Anthony Mato Anthony Mato tal
ASCO/EHA/ICML 2021 - Carol Moreno Carol Moreno hig